Lite Strategy, Inc. (LITS) Stock

NASDAQ: LITSHealthcare company in the biotechnology industry, based in San Diego, CA.

Lite Strategy stock price chart

LITS interactive chart →

LITS stock quote & key statistics

Lite Strategy earnings per share

Income →
Earnings per share

Lite Strategy revenue & net income

Income →
RevenueNet income

Lite Strategy annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$0-$15.9M-$2.39
FY2024$65.3M$17.8M$4.30
FY2023$48.8M-$31.8M-$5.03
FY2022$40.7M-$54.5M-$7.42

Fiscal year ending June 30. Source: company filings via EODHD.

About Lite Strategy, Inc.

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Lite Strategy stock FAQ

What is the Lite Strategy stock ticker symbol?

Lite Strategy, Inc. trades on the NASDAQ under the ticker symbol LITS.

What sector and industry is Lite Strategy in?

Lite Strategy, Inc. is classified in the Healthcare sector, Biotechnology industry.

How many employees does Lite Strategy have?

Lite Strategy, Inc. has about 5 full-time employees.

What were Lite Strategy's revenue and earnings last fiscal year?

Lite Strategy reported revenue of $0 and net income of -$15.9M in fiscal 2025, with earnings per share of -$2.39. Revenue declined 100.0% from the prior year.

When did Lite Strategy go public?

Lite Strategy stock began trading on December 18, 2003.

Biotechnology stocks

All Healthcare stocks →